glp 1 and antipsychotics GLP-1 Receptor Agonists Improve Metabolic Outcomes in Schizophrenia Patients on Antipsychotics: JAMA GLP-1 medications get at the

Nat Rev Neurol 21 , 687705 (2025)

In concert, these results define a new scenario of action for incretin-based therapy that may involve the adipo-insular axis, linking the weight lowering competence with the sustained protection of -cells from diabetogenic stressors

The MIC componentsMethionine, Inositol, and Cholineaid the liver in breaking down fat and preventing fat accumulation, while B12 enhances metabolism and energy levels

A Previous study proposed that -sitosterol promotes the endosomal escape of lipid particles 15

Clinical trials including the STEP program, which enrolled over 4,500 patients, did not identify brain fog as a primary adverse effect